Precigen to announce first quarter 2023 financial results on may 10th

Germantown, md. , may 3, 2023 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the company will release first quarter 2023 financial results on wednesday, may 10, 2023.
PGEN Ratings Summary
PGEN Quant Ranking